Zilico
Manchester
About Zilico
Zilico is developing the next generation of cancer diagnostics that will provide real-time diagnosis for cervical cancer and reduce the inherent subjectivity of current methods. Two applications are under development: the first for the referral market and the second for the screening market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.7M
- Last round: Grant (May 2019)
- Website: zilico.co.uk
- Phone: 0161 826 7840
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/zilico-73841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.